Chin-Chun Lu

2.5k total citations
10 papers, 1.0k citations indexed

About

Chin-Chun Lu is a scholar working on Molecular Biology, Hematology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chin-Chun Lu has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chin-Chun Lu's work include Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Chin-Chun Lu is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Chin-Chun Lu collaborates with scholars based in United States and Russia. Chin-Chun Lu's co-authors include Yimin Zou, Jun Shi, Adam M. Schmitt, Leslie A. King, Anna I Lyuksyutova, Xue‐Jun Song, Gang Lu, Brian E. Cathers, Yaobo Liu and Oswald Steward and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Chin-Chun Lu

10 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chin-Chun Lu United States 9 708 432 184 165 126 10 1.0k
Robert Tighe United States 3 643 0.9× 516 1.2× 89 0.5× 276 1.7× 185 1.5× 5 1.1k
Catherine Vaillant Switzerland 8 439 0.6× 249 0.6× 66 0.4× 91 0.6× 82 0.7× 20 724
Elisabeth Casademunt Germany 11 457 0.6× 496 1.1× 110 0.6× 183 1.1× 89 0.7× 11 844
Paula Scotland United States 10 548 0.8× 218 0.5× 39 0.2× 47 0.3× 212 1.7× 15 817
Jochen Kinter Switzerland 12 454 0.6× 171 0.4× 93 0.5× 39 0.2× 271 2.2× 21 895
Muriel Bozon France 19 407 0.6× 564 1.3× 51 0.3× 254 1.5× 313 2.5× 36 1.1k
Stephen Matheson United States 8 466 0.7× 279 0.6× 51 0.3× 82 0.5× 295 2.3× 13 803
Eva Reinhard Switzerland 12 398 0.6× 354 0.8× 293 1.6× 189 1.1× 242 1.9× 13 969
Joanna M. Solowska United States 17 500 0.7× 631 1.5× 28 0.2× 214 1.3× 523 4.2× 17 1.3k
Emmanuelle Clérin France 13 1.1k 1.6× 557 1.3× 51 0.3× 90 0.5× 79 0.6× 29 1.3k

Countries citing papers authored by Chin-Chun Lu

Since Specialization
Citations

This map shows the geographic impact of Chin-Chun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin-Chun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin-Chun Lu more than expected).

Fields of papers citing papers by Chin-Chun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin-Chun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin-Chun Lu. The network helps show where Chin-Chun Lu may publish in the future.

Co-authorship network of co-authors of Chin-Chun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chin-Chun Lu. A scholar is included among the top collaborators of Chin-Chun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin-Chun Lu. Chin-Chun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lopez‐Girona, Antonia, Gang Lu, Emily Rychak, et al.. (2019). CC-90009, a Novel Cereblon E3 Ligase Modulator, Targets GSPT1 for Degradation to Induce Potent Tumoricidal Activity Against Acute Myeloid Leukemia (AML). Blood. 134(Supplement_1). 2703–2703. 16 indexed citations
2.
Lopez‐Girona, Antonia, Courtney G. Havens, Gang Lu, et al.. (2019). CC-92480 Is a Novel Cereblon E3 Ligase Modulator with Enhanced Tumoricidal and Immunomodulatory Activity Against Sensitive and Resistant Multiple Myeloma Cells. Blood. 134(Supplement_1). 1812–1812. 18 indexed citations
3.
Lu, Gang, Christine Surka, Chin-Chun Lu, et al.. (2019). Elucidating the Mechanism of Action of CC-90009, a Novel Cereblon E3 Ligase Modulator, in AML Via Genome-Wide CRISPR Screen. Blood. 134(Supplement_1). 405–405. 7 indexed citations
4.
Lu, Gang, Mary E. Matyskiela, Xinde Zheng, et al.. (2018). UBE2G1 governs the destruction of cereblon neomorphic substrates. eLife. 7. 56 indexed citations
5.
Nguyen, Thang Van, Jing Li, Chin-Chun Lu, et al.. (2017). p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates. Proceedings of the National Academy of Sciences. 114(14). 3565–3571. 68 indexed citations
6.
Matyskiela, Mary E., Weihong Zhang, Hon‐Wah Man, et al.. (2017). A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos. Journal of Medicinal Chemistry. 61(2). 535–542. 203 indexed citations
7.
Hansen, Joshua D., Kevin R. Condroski, Matthew Correa, et al.. (2017). Protein Degradation via CRL4CRBN Ubiquitin Ligase: Discovery and Structure–Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1. Journal of Medicinal Chemistry. 61(2). 492–503. 60 indexed citations
8.
Liu, Yaobo, Xiaofei Wang, Chin-Chun Lu, et al.. (2008). Repulsive Wnt Signaling Inhibits Axon Regeneration after CNS Injury. Journal of Neuroscience. 28(33). 8376–8382. 138 indexed citations
9.
Schmitt, Adam M., et al.. (2005). Wnt–Ryk signalling mediates medial–lateral retinotectal topographic mapping. Nature. 439(7072). 31–37. 227 indexed citations
10.
Shi, Jun, et al.. (2005). Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract. Nature Neuroscience. 8(9). 1151–1159. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026